pirfenidone has been researched along with Carcinoma, Ductal, Pancreatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Z; Li, Z; Liang, J; Liu, Y; Lv, Y; Shen, S; Shen, Y; Wang, L; Xu, G; Zhang, F; Zhang, S; Zhang, Y; Zhao, J; Zhou, S; Zhu, Y; Zou, X | 1 |
| Caires, HR; Castro, I; Cavadas, B; Ferreira, D; Oliveira, MJ; Pereira, L; Santos, LL; Vasconcelos, MH; Xavier, CPR | 1 |
| Cardone, RA; Carvalho, TMA; Koltai, T; Reshkin, SJ | 1 |
3 other study(ies) available for pirfenidone and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
Pirfenidone-loaded exosomes derived from pancreatic ductal adenocarcinoma cells alleviate fibrosis of premetastatic niches to inhibit liver metastasis.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Exosomes; Humans; Liver Cirrhosis; Liver Neoplasms; Pancreatic Neoplasms | 2022 |
Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine.
Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chitinase-3-Like Protein 1; Deoxycytidine; Drug Resistance, Neoplasm; Extracellular Vesicles; Fibronectins; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Macrophages; Pancreatic Neoplasms; Pentoxifylline; Proteomics; Pyridones; Survival Analysis; Up-Regulation | 2021 |
Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer.
Topics: Adenocarcinoma; Bromelains; Carcinoma, Pancreatic Ductal; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Hyaluronan Synthases; Hyaluronic Acid; Hymecromone; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Metastasis; Pyridones; Signal Transduction | 2021 |